Spine Planning (3.0); Spine & Trauma Navigation; Alignment System Spine
Brainlab SE · Decision date Sep 30, 2026
What did the FDA decide?
FDA recorded a substantially equivalent decision for K262257 on 2026-09-30, covering Spine Planning (3.0), Spine & Trauma Navigation and Alignment System Spine, submitted by Brainlab SE of Munich, Germany. The filing is a traditional 510(k) under regulation 882.4560, device classification Orthopedic Stereotaxic Instrument, product code OLO, with Neurology as the regulation medical specialty and the Orthopedic panel as reviewer. The decision is a clearance, not a PMA approval.
The reviewed documents describe Spine Planning software for pre-operative or intra-operative spinal surgery planning, displaying 2D X-ray and 3D images, with vertebrae labeling and measurement on 2D images and vertebra detection on Digitally Reconstructed Radiograph images of 3D datasets for atlas registration. The documents also describe screw and interbody device planning and navigation with surgical instruments. The source does not state which elements are new relative to prior clearances, and no summary statement text is present in the supplied data.
The record lists a 07/02/2026 receipt date and a page update of 11/02/2026. The supplied excerpts truncate the indication statement, so the full labeled indications, patient-selection criteria and any clinical performance data remain unknown from this material.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Neurology
- Decision date
- Sep 30, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262257
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Brainlab SE
- Product code
- OLO
- Decision code
- SESE
- Decision date
- Sep 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Orthopedic Stereotaxic Instrument.
- Applicant
- Brainlab SE
- Product code
- OLO
- FDA device class
- 2
FDA decision timeline
K262257 received
Application receipt date recorded by FDA.
K262257 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code OLO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
GPS AnkleK262567 | Blue Ortho | 510(k) clearance | Oct 26, 2026 | FDA |
7D Surgical System (10-0001)K260403 | 7D Surgical ULC | 510(k) clearance | Oct 19, 2026 | FDA |
| THINK Surgical, Inc. | 510(k) clearance | Oct 16, 2026 | FDA | |
| CarboFix Orhtopedics , Ltd. | 510(k) clearance | Oct 9, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Brainlab SE
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Munich
Sources and methodology
- Original FDA record: K262257
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


